PMC:3406298 / 11469-12178 JSONTXT

{"target":"http://pubannotation.org/docs/sourcedb/PMC/sourceid/3406298","sourcedb":"PMC","sourceid":"3406298","source_url":"https://www.ncbi.nlm.nih.gov/pmc/3406298","text":"Efficacy\nDiary documented self-assessment nasal and non-nasal symptom scores at baseline and end of the treatment period are presented in Fig. 2, with no significant differences between the groups on the severity of these symptoms. There were no significant differences between the two groups in all domains of the fortnightly RQLQ scores throughout the study (Table 3).\nThere were no statistically significant differences in mean relief medication score within or between the RCM-104 and placebo groups between the baseline and the final visit (Table 4). Based on responses to the type of treatment received, there was no significant difference in the responses (χ2 = 2.03, p = 0.363) between the two groups.","divisions":[{"label":"Title","span":{"begin":0,"end":8}}],"tracks":[]}